Tacca, Nicholas
Levine, Jackson T.
Heimann, Mary K.
Schlink, Bryan R.
Cady, Sedona
Colachis, Samuel C.
Baumgart, Ian
Bollinger, Austin
Dunlap, Collin
Putnam, Philip
Darrow, Michael J.
Wengerd, Lauren
Pons, José L.
Friedenberg, David A.
Meyers, Eric C.
Funding for this research was provided by:
Internal Battelle R&D funds (N/A)
Internal Battelle R&D funds (N/A)
Internal Battelle R&D funds (N/A)
Internal Battelle R&D funds (N/A)
Internal Battelle R&D funds (N/A)
Internal Battelle R&D funds (N/A)
Internal Battelle R&D funds (N/A)
Internal Battelle R&D funds (N/A)
Internal Battelle R&D funds (N/A)
Internal Battelle R&D funds (N/A)
Article History
Received: 5 June 2025
Accepted: 10 November 2025
First Online: 8 January 2026
Declarations
:
: Data were collected as part of an ongoing clinical study (IRB0773, IRB 0779) being conducted at Battelle Memorial Institute that was approved by the Battelle Memorial Institute Institutional Review Board. All participants provided written informed consent before participation, in accordance with the Declaration of Helsinki.
: Consent was obtained from participants for publication of these data.
: The authors declare no Conflict of interest.
: The NeuroLife® RECLAIM TM EMG sleeve was used in the study referenced. This device has not been approved or cleared as safe or effective by FDA. This device is limited by U.S. federal law to investigational use.